How German vascular surgeons and angiologists judge walking exercise for patients with PAD
Results from a nationwide survey amongst 743 members of two major scientific societies
Abstract
Summary:Background: To determine the physician’s perspective and perception on walking exercise as well as barriers in guideline-directed best medical treatment of patients with lower extremity peripheral arterial disease (PAD). Patients and methods: All members of the German Society for Vascular Surgery and Vascular Medicine and of the German Society for Angiology – Society for Vascular Medicine with valid email address were invited to participate in an electronic survey on walking exercise for treatment of intermittent claudication that was developed by the authors. Results: Amongst 3910 invited participants, 743 (19%) provided valid responses (33% females, 84% vascular surgery, 15% angiology). Thereof, 65% were employed by non-university hospitals, 16% by university institutions, and 18% by outpatient facilities. A mean of 14 minutes were spent per patient to counsel and educate, while only 53% responded they had enough time in everyday clinical practice. While 98% were aware of the beneficial impact of structured exercise training (SET) on pain free walking distance and 90% advise their patients to adhere to SET, only 44% provided useful guidance to patients to find local SET programmes and merely 42% knew how to prescribe SET as service that can be reimbursed by medical insurances. Approximately 35% knew a local SET programme and appropriate contact person. Health-related quality of life was assessed in a structured way by only 11%. Forty-seven percent responded that medical insurances should be responsible to implement and maintain SET programmes, while only 4% held hospital physicians responsible to achieve this task. Conclusions: This nationwide survey study amongst vascular specialists illustrates the current insufficient utilisation of SET as an evidence-based therapeutic cornerstone in patients with lower extremity PAD in Germany. The study also identified several barriers and flaws from the physician’s perspectives which should be addressed collectively by all health care providers aiming to increase the SET use and eventually its’ impact on patients with PAD.
References
1 Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020–e30.
2 Editor’s Choice – Prevalence of peripheral arterial disease, abdominal aortic aneurysm, and risk factors in the Hamburg City Health Study: A Cross-Sectional Analysis. Eur J Vasc Endovasc Surg. 2023;S1078-5884(23)00004-7.
3 Editor’s choice – Comorbidity patterns among patients with peripheral arterial occlusive disease in Germany: a trend analysis of health insurance claims data. Eur J Vasc Endovasc Surg. 2020;59:59–66.
4 Editor’s choice – International variations and sex disparities in the treatment of peripheral arterial occlusive disease: a report from VASCUNET and the International Consortium of Vascular Registries. Eur J Vasc Endovasc Surg. 2020;60:873–80.
5 Editor’s choice – 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:305–68.
6 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017;135:e726–e79.
7 ESVM Guideline on peripheral arterial disease. Vasa. 2019;48:1–79.
8 . German guideline on the diagnosis and treatment of peripheral artery disease – a comprehensive update 2016. Vasa. 2017;46:79–86.
9 A delphi consensus on patient reported outcomes for registries and trials including patients with intermittent claudication: recommendations and reporting standard. Eur J Vasc Endovasc Surg. 2022;64:526–33.
10 Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg. 2023;77:506–14.
11 A prospective survey study on the education and awareness about walking exercise amongst inpatients with symptomatic peripheral arterial disease in Germany. Vasa. 2023. Online ahead of print. https://doi.org/10.1024/0301-1526/a001057
12 Distribution of mobile health applications amongst patients with symptomatic peripheral arterial disease in Germany: a cross-sectional survey study. J Clin Med. 2022;11:498.
13 . Patient reported outcomes: the missing link in symptomatic vascular disease outcome assessment. Eur J Vasc Endovasc Surg. 2022;63(3):464.
14 Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners. BMJ Open Sport Exerc Med. 2020;6:e000897.
15 . Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;12:CD000990.
16 Supervised walking therapy in patients with intermittent claudication. J Vasc Surg. 2012;56:1132–42.
17 . Gait changes after supervised exercise training in patients with symptomatic lower extremity peripheral artery disease. Vasc Med. 2021;26:259–66.
18 . Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2015;20:30–40.
19 . Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med. 2015;45:231–44.
20 International variations and gender disparities in the treatment of peripheral arterial occlusive disease – a report from VASCUNET and the International Consortium of Vascular Registries. Eur J Vasc Endovasc Surg. 2020;60(6):873–80.
21 . The relationship between hospital procedure volume and outcomes after endovascular or open surgical revascularisation for peripheral arterial disease: an analysis of health insurance claims data. Eur J Vasc Endovasc Surg. 2023;65(3):370–8.
